FMC (NYSE:FMC) released its earnings results on Monday. The basic materials company reported $1.10 EPS for the quarter, beating analysts’ consensus estimates of $1.05 by $0.05, Bloomberg Earnings reports. The firm had revenue of $979.60 million for the quarter, compared to analysts’ expectations of $993.57 million. FMC had a return on equity of 16.77% and a net margin of 0.78%. The company’s quarterly revenue was up 42.3% on a year-over-year basis. During the same quarter in the prior year, the firm posted $0.88 earnings per share. FMC updated its Q1 guidance to $1.45-1.59 EPS and its FY18 guidance to $5.20-5.60 EPS.

Shares of FMC (NYSE FMC) opened at $85.22 on Tuesday. The company has a current ratio of 2.19, a quick ratio of 1.81 and a debt-to-equity ratio of 0.70. The firm has a market capitalization of $11,100.77, a price-to-earnings ratio of 501.29, a price-to-earnings-growth ratio of 1.37 and a beta of 1.52. FMC has a twelve month low of $57.29 and a twelve month high of $98.70.

The business also recently announced a quarterly dividend, which was paid on Thursday, January 18th. Shareholders of record on Friday, December 29th were issued a dividend of $0.165 per share. The ex-dividend date of this dividend was Thursday, December 28th. This represents a $0.66 dividend on an annualized basis and a yield of 0.77%. FMC’s dividend payout ratio is currently 388.24%.

In other FMC news, insider Nicholas Pfeiffer sold 375 shares of the company’s stock in a transaction on Tuesday, December 12th. The stock was sold at an average price of $90.33, for a total transaction of $33,873.75. Following the completion of the sale, the insider now owns 6,856 shares in the company, valued at $619,302.48. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. 1.10% of the stock is owned by corporate insiders.

Several research analysts recently issued reports on FMC shares. Zacks Investment Research raised FMC from a “hold” rating to a “buy” rating and set a $101.00 price objective on the stock in a research note on Monday, December 18th. Credit Suisse Group set a $111.00 price objective on FMC and gave the stock a “buy” rating in a research note on Tuesday, January 16th. Bank of America increased their price objective on FMC from $103.00 to $105.00 and gave the stock a “buy” rating in a research note on Wednesday, November 8th. Goldman Sachs Group started coverage on FMC in a research note on Monday, December 4th. They issued a “neutral” rating and a $98.00 price objective on the stock. Finally, Stephens started coverage on FMC in a research note on Monday, December 4th. They issued an “equal weight” rating and a $91.00 price objective on the stock. Eight analysts have rated the stock with a hold rating and fourteen have issued a buy rating to the stock. The company presently has an average rating of “Buy” and a consensus target price of $96.58.

COPYRIGHT VIOLATION NOTICE: This piece was published by Daily Political and is the sole property of of Daily Political. If you are viewing this piece on another domain, it was illegally copied and reposted in violation of United States & international copyright law. The legal version of this piece can be accessed at

FMC Company Profile

FMC Corporation is a diversified chemical company serving agricultural, consumer and industrial markets. The Company operates in three business segments: FMC Agricultural Solutions, FMC Health and Nutrition, and FMC Lithium. As of December 31, 2016, the FMC Agricultural Solutions segment developed, marketed and sold three classes of crop protection chemicals: insecticides, herbicides and fungicides.

Earnings History for FMC (NYSE:FMC)

Receive News & Ratings for FMC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for FMC and related companies with's FREE daily email newsletter.